Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963123 | Vaccine | 2015 | 6 Pages |
Abstract
The reported IV prevalence was higher than that of 24- to 59-month-old children reported in other studies. There is room for improvement through health promotion, which should modify parental cognitions related to HBM (except perceived severity and self-efficacy) and involve family members to create subjective norm. Media campaigns may be inadequate for promotion of IV; use of the setting approach may be considered.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Anise M.S. Wu, Joseph T.F. Lau, Yee Ling Ma, Mason M.C. Lau,